2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Osteoporosis, Postmenopausal in 1 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Osteoporosis, Postmenopausal: Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, RP | 1 |
| Lin, SJ | 1 |
| Wan, WB | 1 |
| Zuo, HL | 1 |
| Yao, FF | 1 |
| Ruan, HB | 1 |
| Xu, J | 1 |
| Song, W | 1 |
| Zhou, YC | 1 |
| Wen, SY | 1 |
| Dai, JH | 1 |
| Zhu, ML | 1 |
| Luo, J | 1 |
1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Chlorogenic Acid Prevents Osteoporosis by Shp2/PI3K/Akt Pathway in Ovariectomized Rats.
Topics: Animals; Bone Density; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chlorogenic Acid; | 2016 |